Our Pricing

Understanding the Wegovy Dose Schedule: Your Complete UK Guide

Published on: June 03, 2026

Searching for clear information on the wegovy dose schedule uk online? At Cured Pharmacy, we provide genuine UK-licensed Wegovy injections from £79.00 with transparent dosing guidance and free clinical consultation from our UK-registered prescribers. Understanding Wegovy's gradual titration schedule is essential for maximising weight loss results whilst minimising side effects.

The Complete Wegovy Dose Schedule Explained

Wegovy (semaglutide) follows a structured 16-week dose escalation schedule designed to improve gastrointestinal tolerability whilst building therapeutic efficacy [1]. Unlike medications that start at full strength, Wegovy's gradual titration allows your body to adapt to the GLP-1 receptor agonist mechanism, significantly reducing the risk of nausea and vomiting that can occur with rapid dose increases.

The standard UK-licensed Wegovy dose schedule progresses through five escalation phases: 0.25mg weekly for 4 weeks, 0.5mg weekly for 4 weeks, 1.0mg weekly for 4 weeks, 1.7mg weekly for 4 weeks, and finally the maintenance dose of 2.4mg weekly [1]. Each pen is pre-filled and colour-coded to prevent dosing errors, with the dose clearly marked on the label.

Clinical data from the STEP programme demonstrated that patients who completed the full titration schedule and reached the 2.4mg maintenance dose achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [2]. The gradual dose escalation was crucial to this success, with only 4.5% of participants discontinuing due to gastrointestinal adverse events when following the recommended schedule [1].

Week-by-Week Wegovy Dosing Protocol

During weeks 1-4, you'll inject 0.25mg of Wegovy once weekly. This initial dose is sub-therapeutic, meaning it's designed primarily to introduce the medication gradually rather than produce significant weight loss. Most patients report minimal side effects at this stage, though mild nausea may occur as your body adjusts to the GLP-1 mechanism.

Weeks 5-8 increase to 0.5mg weekly, where many patients begin noticing reduced appetite and early weight loss. The 1.0mg dose during weeks 9-12 typically produces more pronounced appetite suppression and steady weight reduction. Weeks 13-16 at 1.7mg represent the final escalation before maintenance, with most patients experiencing consistent weekly weight loss by this stage.

From week 17 onwards, the 2.4mg maintenance dose is continued indefinitely, subject to ongoing prescriber review [1]. Your UK prescriber at Cured Pharmacy will monitor your progress throughout the titration schedule and may adjust the timeline if you experience persistent side effects or require additional time at a particular dose level.

What Happens If You Miss a Dose?

If you miss your scheduled Wegovy injection and it's been less than 5 days since your missed dose, take it as soon as you remember and continue your regular weekly schedule [1]. If more than 5 days have passed, skip the missed dose entirely and resume with your next scheduled injection. Never double up doses to compensate for a missed injection, as this increases the risk of gastrointestinal side effects without additional therapeutic benefit.

Why Wegovy Uses a Gradual Titration Schedule

The 16-week dose escalation isn't arbitrary—it's based on extensive pharmacokinetic data showing that semaglutide takes approximately 4-5 weeks to reach steady-state concentrations at each dose level [1]. Rushing this process by increasing doses too quickly overwhelms GLP-1 receptors in the gastrointestinal tract, triggering the nausea, vomiting, and diarrhoea that cause many patients to discontinue treatment prematurely.

GLP-1 receptor agonists like semaglutide slow gastric emptying as part of their mechanism of action, which contributes to both appetite suppression and the common side effect of nausea [2]. By introducing the medication gradually, your digestive system adapts to this altered gastric motility, typically resulting in side effects that peak during the first few days after each dose increase and then subside.

Clinical trials comparing accelerated versus standard titration schedules consistently demonstrate that the gradual 16-week protocol produces superior treatment persistence and comparable weight loss outcomes [1]. Patients who attempt to skip doses or accelerate the schedule independently experience discontinuation rates up to three times higher than those following the licensed titration protocol.

Wegovy Dose Schedule vs Other Weight Loss Injections

Saxenda (liraglutide) requires daily injections and a 5-week titration schedule, starting at 0.6mg and increasing by 0.6mg weekly to a maintenance dose of 3.0mg daily. Whilst the shorter titration period may seem appealing, the daily injection frequency and higher incidence of injection site reactions make it less convenient for many patients compared to Wegovy's once-weekly schedule.

The key advantage of Wegovy's once-weekly dosing lies in both convenience and the pharmacokinetic profile of semaglutide, which has a half-life of approximately 7 days [1]. This extended half-life maintains stable therapeutic concentrations throughout the week, producing consistent appetite suppression without the peaks and troughs associated with daily injections.

Your UK prescriber will assess which treatment schedule best suits your lifestyle, medical history, and weight loss goals during your free online consultation at Cured Pharmacy. All prescription weight loss medications require ongoing clinical monitoring and are dispensed subject to prescriber approval.

Adjusting Your Dose Schedule

Some patients require additional time at a particular dose level if they experience persistent gastrointestinal side effects. Your prescriber may recommend staying at your current dose for an extra 4 weeks before escalating, which is a clinically appropriate modification to the standard schedule [1]. Never adjust your dose independently—always consult your prescriber before making any changes to your Wegovy schedule.

Starting Your Wegovy Dose Schedule at Cured Pharmacy

Beginning treatment at Cured Pharmacy starts with a free online consultation that takes under 3 minutes to complete. Our UK-registered prescribers review your medical history, current medications, and weight loss goals to determine if Wegovy is clinically appropriate for you. If approved, your prescription is issued and your first dose is dispensed from our GPhC-registered pharmacy (registration number 9012511).

We supply Wegovy in monthly packs containing four pre-filled pens at your prescribed dose strength, with clear instructions for injection technique and dose progression. Your treatment includes access to our clinical team for ongoing support throughout your titration schedule, and we'll coordinate your dose escalations to ensure seamless progression through each phase.

Wegovy is priced from £79.00 at Cured Pharmacy, with transparent upfront costs shown before your consultation. All UK-licensed medicines are dispensed in discreet packaging with next-day delivery available. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical services to ensure you receive safe, effective treatment throughout your weight loss journey.

Maximising Results During Your Dose Schedule

Clinical trials demonstrate that patients who combine Wegovy with reduced-calorie dietary changes and increased physical activity achieve significantly greater weight loss than those relying on medication alone [2]. The STEP 1 trial showed that participants following a structured lifestyle intervention alongside Wegovy lost an average 16.9% of body weight, compared to 14.9% with Wegovy and standard dietary advice [2].

During your titration schedule, focus on establishing sustainable eating patterns rather than pursuing aggressive calorie restriction. Wegovy's appetite-suppressing effects make it easier to reduce portion sizes naturally, but adequate protein intake (1.2-1.6g per kilogram of body weight) helps preserve lean muscle mass during weight loss. Staying well-hydrated is particularly important, as GLP-1 medications can slow gastric emptying and increase the risk of constipation.

Regular physical activity doesn't need to be intense to support your weight loss—the NHS recommends 150 minutes of moderate activity weekly, which could include brisk walking, cycling, or swimming. Many patients find that as weight decreases during the dose schedule, physical activity becomes progressively easier and more enjoyable, creating a positive reinforcement cycle that supports long-term weight management.

Monitoring Your Progress

Your prescriber will schedule regular reviews to assess your response to treatment, typically at 12-16 week intervals. NICE guidance recommends discontinuing Wegovy if you haven't achieved at least 5% weight loss after 6 months at the maintenance dose, as continued treatment is unlikely to produce clinically meaningful results [3]. Most patients who respond well to Wegovy notice consistent weight loss throughout the titration schedule, with results accelerating as they approach the 2.4mg maintenance dose.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine licensed by the MHRA for weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities, alongside reduced-calorie diet and increased physical activity. Individual results may vary. Common side effects include nausea, diarrhoea, vomiting, constipation, and abdominal pain. For full prescribing information, consult the Summary of Product Characteristics.